767264-22-2 Usage
Uses
Used in Pharmaceutical Synthesis:
3-Methoxy-2,2-dimethylpropylamine is used as an intermediate in the synthesis of various pharmaceuticals and organic compounds. Its unique chemical structure allows it to be a key component in the production of a range of medications and other chemical products.
Used in Chemical Reactions:
In the field of chemistry, 3-Methoxy-2,2-dimethylpropylamine is used as a reagent in various chemical reactions. Its properties as a tertiary amine make it a valuable asset in facilitating specific chemical processes and transformations.
Used in Organic Synthesis Research:
3-Methoxy-2,2-dimethylpropylamine is also utilized in research for its potential applications in organic synthesis. Scientists are exploring its capabilities and interactions within different chemical systems to discover new methods and compounds that can be synthesized using MMDA as a starting material or catalyst.
Check Digit Verification of cas no
The CAS Registry Mumber 767264-22-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,6,7,2,6 and 4 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 767264-22:
(8*7)+(7*6)+(6*7)+(5*2)+(4*6)+(3*4)+(2*2)+(1*2)=192
192 % 10 = 2
So 767264-22-2 is a valid CAS Registry Number.
InChI:InChI=1/C6H15NO/c1-6(2,4-7)5-8-3/h4-5,7H2,1-3H3
767264-22-2Relevant academic research and scientific papers
NOVEL IMIDAZO BASED HETEROCYCLES
-
Page/Page column 49-50, (2010/11/26)
The present invention is directed to novel imidazopyrazine and imidazopyrimidine compounds of formula (I), wherein the variables are as defined herein. The compounds of formula (I) are useful as kinase inhibitors and as such would be useful in treating ce
1-BENZYLINDOLE-2-CARBOXAMIDE DERIVATIVES
-
Page/Page column 54, (2010/11/24)
The present invention relates to i-benzylindole-2-carboxamide derivatives of formula I, or a pharmaceutically acceptable salt or solvate thereof. The invention also relates to pharmaceutical compositions comprising said 1-benzylindole-2-carboxamide deriva